166 related articles for article (PubMed ID: 33789210)
1. Clinicopathological correlations and cholinesterase expression in early-onset familial Alzheimer's disease with the presenilin 1 mutation, Leu235Pro.
Cash MK; Rockwood K; Fisk JD; Darvesh S
Neurobiol Aging; 2021 Jul; 103():31-41. PubMed ID: 33789210
[TBL] [Abstract][Full Text] [Related]
2. Neurons derived from sporadic Alzheimer's disease iPSCs reveal elevated TAU hyperphosphorylation, increased amyloid levels, and GSK3B activation.
Ochalek A; Mihalik B; Avci HX; Chandrasekaran A; Téglási A; Bock I; Giudice ML; Táncos Z; Molnár K; László L; Nielsen JE; Holst B; Freude K; Hyttel P; Kobolák J; Dinnyés A
Alzheimers Res Ther; 2017 Dec; 9(1):90. PubMed ID: 29191219
[TBL] [Abstract][Full Text] [Related]
3. Amyloid generation and dysfunctional immunoproteasome activation with disease progression in animal model of familial Alzheimer's disease.
Aso E; Lomoio S; López-González I; Joda L; Carmona M; Fernández-Yagüe N; Moreno J; Juvés S; Pujol A; Pamplona R; Portero-Otin M; Martín V; Díaz M; Ferrer I
Brain Pathol; 2012 Sep; 22(5):636-53. PubMed ID: 22188425
[TBL] [Abstract][Full Text] [Related]
4. AMY plaques in familial AD: comparison with sporadic Alzheimer's disease.
Lippa CF; Schmidt ML; Nee LE; Bird T; Nochlin D; Hulette C; Mori H; Lee VM; Trojanowski JQ
Neurology; 2000 Jan; 54(1):100-4. PubMed ID: 10636133
[TBL] [Abstract][Full Text] [Related]
5. Lewy bodies contain altered alpha-synuclein in brains of many familial Alzheimer's disease patients with mutations in presenilin and amyloid precursor protein genes.
Lippa CF; Fujiwara H; Mann DM; Giasson B; Baba M; Schmidt ML; Nee LE; O'Connell B; Pollen DA; St George-Hyslop P; Ghetti B; Nochlin D; Bird TD; Cairns NJ; Lee VM; Iwatsubo T; Trojanowski JQ
Am J Pathol; 1998 Nov; 153(5):1365-70. PubMed ID: 9811326
[TBL] [Abstract][Full Text] [Related]
6. Enhanced accumulation of phosphorylated alpha-synuclein and elevated beta-amyloid 42/40 ratio caused by expression of the presenilin-1 deltaT440 mutant associated with familial Lewy body disease and variant Alzheimer's disease.
Kaneko H; Kakita A; Kasuga K; Nozaki H; Ishikawa A; Miyashita A; Kuwano R; Ito G; Iwatsubo T; Takahashi H; Nishizawa M; Onodera O; Sisodia SS; Ikeuchi T
J Neurosci; 2007 Nov; 27(48):13092-7. PubMed ID: 18045903
[TBL] [Abstract][Full Text] [Related]
7. Neuropathology and biochemistry of early onset familial Alzheimer's disease caused by presenilin-1 missense mutation Thr116Asn.
Sutovsky S; Smolek T; Turcani P; Petrovic R; Brandoburova P; Jadhav S; Novak P; Attems J; Zilka N
J Neural Transm (Vienna); 2018 Jun; 125(6):965-976. PubMed ID: 29404783
[TBL] [Abstract][Full Text] [Related]
8. NACP/alpha-synuclein, NAC, and beta-amyloid pathology of familial Alzheimer's disease with the E184D presenilin-1 mutation: a clinicopathological study of two autopsy cases.
Yokota O; Terada S; Ishizu H; Ujike H; Ishihara T; Nakashima H; Yasuda M; Kitamura Y; Uéda K; Checler F; Kuroda S
Acta Neuropathol; 2002 Dec; 104(6):637-48. PubMed ID: 12410385
[TBL] [Abstract][Full Text] [Related]
9. Regional distribution of synaptic markers and APP correlate with distinct clinicopathological features in sporadic and familial Alzheimer's disease.
Shinohara M; Fujioka S; Murray ME; Wojtas A; Baker M; Rovelet-Lecrux A; Rademakers R; Das P; Parisi JE; Graff-Radford NR; Petersen RC; Dickson DW; Bu G
Brain; 2014 May; 137(Pt 5):1533-49. PubMed ID: 24625695
[TBL] [Abstract][Full Text] [Related]
10. Synergistic Interactions between Abeta, tau, and alpha-synuclein: acceleration of neuropathology and cognitive decline.
Clinton LK; Blurton-Jones M; Myczek K; Trojanowski JQ; LaFerla FM
J Neurosci; 2010 May; 30(21):7281-9. PubMed ID: 20505094
[TBL] [Abstract][Full Text] [Related]
11. Aluminum and Neurofibrillary Tangle Co-Localization in Familial Alzheimer's Disease and Related Neurological Disorders.
Mold MJ; O'Farrell A; Morris B; Exley C
J Alzheimers Dis; 2020; 78(1):139-149. PubMed ID: 32925074
[TBL] [Abstract][Full Text] [Related]
12. Reduced Reelin expression accelerates amyloid-beta plaque formation and tau pathology in transgenic Alzheimer's disease mice.
Kocherhans S; Madhusudan A; Doehner J; Breu KS; Nitsch RM; Fritschy JM; Knuesel I
J Neurosci; 2010 Jul; 30(27):9228-40. PubMed ID: 20610758
[TBL] [Abstract][Full Text] [Related]
13. A three-dimensional human neural cell culture model of Alzheimer's disease.
Choi SH; Kim YH; Hebisch M; Sliwinski C; Lee S; D'Avanzo C; Chen H; Hooli B; Asselin C; Muffat J; Klee JB; Zhang C; Wainger BJ; Peitz M; Kovacs DM; Woolf CJ; Wagner SL; Tanzi RE; Kim DY
Nature; 2014 Nov; 515(7526):274-8. PubMed ID: 25307057
[TBL] [Abstract][Full Text] [Related]
14. Neuropathology and cholinesterase expression in the brains of octogenarians and older.
Maxwell SP; Cash MK; Darvesh S
Chem Biol Interact; 2022 Sep; 364():110065. PubMed ID: 35872043
[TBL] [Abstract][Full Text] [Related]
15. Endogenous Murine Amyloid-β Peptide Assembles into Aggregates in the Aged C57BL/6J Mouse Suggesting These Animals as a Model to Study Pathogenesis of Amyloid-β Plaque Formation.
Ahlemeyer B; Halupczok S; Rodenberg-Frank E; Valerius KP; Baumgart-Vogt E
J Alzheimers Dis; 2018; 61(4):1425-1450. PubMed ID: 29376876
[TBL] [Abstract][Full Text] [Related]
16. Cytoskeletal alterations differentiate presenilin-1 and sporadic Alzheimer's disease.
Woodhouse A; Shepherd CE; Sokolova A; Carroll VL; King AE; Halliday GM; Dickson TC; Vickers JC
Acta Neuropathol; 2009 Jan; 117(1):19-29. PubMed ID: 19015863
[TBL] [Abstract][Full Text] [Related]
17. Exploring the Role of Aggregated Proteomes in the Pathogenesis of Alzheimer's Disease.
Narayanan SE; Sekhar N; Rajamma RG; Marathakam A; Al Mamun A; Uddin MS; Mathew B
Curr Protein Pept Sci; 2020; 21(12):1164-1173. PubMed ID: 32957903
[TBL] [Abstract][Full Text] [Related]
18. Tau load is associated with apolipoprotein E genotype and the amount of amyloid beta protein, Abeta40, in sporadic and familial Alzheimer's disease.
Thaker U; McDonagh AM; Iwatsubo T; Lendon CL; Pickering-Brown SM; Mann DM
Neuropathol Appl Neurobiol; 2003 Feb; 29(1):35-44. PubMed ID: 12581338
[TBL] [Abstract][Full Text] [Related]
19. I716F AβPP mutation associates with the deposition of oligomeric pyroglutamate amyloid-β and α-synucleinopathy with Lewy bodies.
Sieczkowski E; Milenkovic I; Venkataramani V; Giera R; Ströbel T; Höftberger R; Liberski PP; Auff E; Wirths O; Bayer TA; Kovacs GG
J Alzheimers Dis; 2015; 44(1):103-14. PubMed ID: 25182745
[TBL] [Abstract][Full Text] [Related]
20. Beta-amyloid, phospho-tau and alpha-synuclein deposits similar to those in the brain are not identified in the eyes of Alzheimer's and Parkinson's disease patients.
Ho CY; Troncoso JC; Knox D; Stark W; Eberhart CG
Brain Pathol; 2014 Jan; 24(1):25-32. PubMed ID: 23714377
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
